ASTS vs RKLB: Which Is the Better Buy in 2026?

Last updated October 2026

Short answer

RKLB is the larger of the two ($32.51B market cap): the incumbent the market prices for continued execution (782.27x forward earnings, beta 2.94). ASTS is the smaller challenger ($15.82B), priced similarly on forward earnings (-31.60x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

ASTS vs RKLB: the tie-breaker metrics

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricASTSRKLBWhat it tells you
Market cap$15.82B$32.51BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E-31.60782.27Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Beta2.712.94Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range1% of range12% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book6.438.71How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Before you buy: how ASTS and RKLB affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ASTS and RKLB share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ASTS and RKLB exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does AST SpaceMobile (ASTS) do?

AST SpaceMobile (ASTS) is building a space-based cellular network designed to deliver broadband directly to ordinary, unmodified smartphones from satellites. Its goal is to let a standard phone connect to its large low-Earth-orbit satellites when it is out of range of terrestrial cell towers, providing coverage in remote areas, at sea, and during outages. The company has launched test and early commercial satellites (including its BlueWalker and BlueBird series) and has signed agreements and investments with major mobile network operators such as AT&T, Verizon, Vodafone, and Rakuten, as well as receiving strategic investment from Google. AST SpaceMobile is pre-profitability and only just generating revenue (~$115 million over the trailing twelve months, against a net loss of ~$619 million), spending heavily to manufacture and launch a constellation before it can generate meaningful subscriber or operator revenue. Headquartered in Midland, Texas, it is a speculative, high-risk, high-reward company whose value depends on successfully deploying its network and converting partnerships into paying traffic.

Full ASTS guide

What does Rocket Lab (RKLB) do?

Rocket Lab (RKLB) is a space company that builds rockets and spacecraft and provides end-to-end space services. Its established business is the Electron, a small orbital launch vehicle that is one of the most frequently flown small rockets in the world, carrying satellites for commercial, government, and defense customers. Rocket Lab is developing Neutron, a larger, partly reusable medium-lift rocket intended to compete for bigger payloads and constellation deployments, directly targeting the market SpaceX dominates.

Full RKLB guide

ASTS vs RKLB: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • ASTS drivers: Direct-to-device opportunity; Mobile-operator partnerships.
  • RKLB drivers: Neutron medium-lift rocket; Space Systems growth.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: AST SpaceMobile is pre-profitability and early-revenue, with heavy ongoing cash burn to build and launch satellites: trailing free cash flow was about -$1.8 billion, against ~$2.29 billion of cash and ~$2.99 billion of debt as of mid-2026. For RKLB, rocket Lab is not yet consistently profitable and invests heavily in Neutron, so cash burn and capital needs are real until that program generates revenue: trailing free cash flow is about -$252 million and the company funded itself with about $1.53 billion of stock sales in the first half of 2026, diluting holders.

ASTS or RKLB: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ASTS if you believe its drivers more; RKLB if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ASTS and RKLB guides.

ASTS vs RKLB: the full fundamentals

ASTS. AST SpaceMobile cannot be valued on current earnings: at ~144x trailing sales and with consensus calling for a 2026 loss of ~$2.29 per share, the ~$16.6 billion market cap is a bet on the constellation and on analysts' ~$582 million revenue estimate for 2027. That bet has been repriced sharply in 2026 as launch timing slipped, with the stock down ~49% year to date as of October 16 and the analyst consensus at hold with a ~$74 mean target. Valuation remains highly sensitive to launch news, and the next checkpoint is the November 9 Q3 report (consensus EPS ~-$0.44 on ~$46 million of revenue).

RKLB. Rocket Lab trades as a high-growth space name valued on its Space Systems revenue, backlog and the future option value of Neutron rather than current profits; forward P/E is not meaningful with expected EPS near zero. Even after falling from a 52-week high of $151 to about $52, the stock sits near 43x trailing sales, so the October 2026 Neutron delay and the November 9 Q3 report (consensus revenue about $257 million) matter more to valuation than near-term earnings.

Headline figures (approximate, October 2026): ASTS shows market cap ~$16.6B (share price ~$42.52 on Oct 16, 2026), revenue (ttm) ~$115M; Q2 2026 ~$31.5M, net income (ttm) ~-$619M loss, EPS ~-$2.13, margins Gross ~39%, operating deeply negative (~-545%); RKLB shows revenue (ttm) ~$769 million, up ~62% year over year in Q2 2026, backlog ~$2.36 billion record (end Q2 2026), gross margin ~37% GAAP TTM; ~41.5% non-GAAP in Q2 2026, operating margin (ttm) ~-25%.

The bottom line: ASTS vs RKLB

ASTS and RKLB are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ASTS and RKLB exposure against your real portfolio. It is not an investment adviser.

Wondering how ASTS or RKLB fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Investing in AST SpaceMobile with AI

Connect the broker you already use and ask Walnut's AI how ASTS fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

What is the difference between ASTS and RKLB?

+

AST SpaceMobile (ASTS) is building a space-based cellular network designed to deliver broadband directly to ordinary, unmodified smartphones from satellites. Rocket Lab (RKLB) is a space company that builds rockets and spacecraft and provides end-to-end space services. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is ASTS or RKLB the better stock?

+

Neither is universally better. RKLB is the larger incumbent; ASTS is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, ASTS or RKLB?

+

On forward P/E (as of October 2026), ASTS trades at -31.60x and RKLB at 782.27x, so ASTS is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both ASTS and RKLB?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of ASTS vs RKLB?

+

ASTS: AST SpaceMobile is pre-profitability and early-revenue, with heavy ongoing cash burn to build and launch satellites: trailing free cash flow was about -$1.8 billion, against ~$2.29 billion of cash and ~$2.99 billion of debt as of mid-2026. It will likely need to raise more capital, which can dilute existing shareholders, and its shares are highly volatile. Major risks include launch failures, technical challenges in delivering reliable direct-to-device service, delays in deploying enough satellites for continuous coverage, competition from other satellite and terrestrial players, and regulatory and spectrum hurdles across many countries. Launch dependence became the dominant risk in 2026: New Glenn's May launch-pad explosion and the loss of BlueBird 7 slowed the deployment schedule, and Piper Sandler has warned that SpaceX, a direct competitor through Starlink Direct to Cell, also controls much of the launch capacity AST relies on. The investment outcome is closer to binary than to a steady compounder. Verify the latest cash position, satellite count, and partnership terms before drawing conclusions. RKLB: Rocket Lab is not yet consistently profitable and invests heavily in Neutron, so cash burn and capital needs are real until that program generates revenue: trailing free cash flow is about -$252 million and the company funded itself with about $1.53 billion of stock sales in the first half of 2026, diluting holders. Neutron faces significant technical, schedule, and ramp risk, and the October 2026 delay of its first launch into 2027 is the latest example; further slips would weigh on the stock, which trades largely on that future option. The launch market is dominated by SpaceX's scale and cost advantages, and competition in small launch and satellite components is intense. Mission failures, supply-chain issues, and lumpy, contract-driven revenue add volatility. At about 43x trailing sales even after a roughly 32% fall in 2026, Rocket Lab remains sensitive to sentiment, funding conditions, and milestone execution rather than steady fundamentals.

Related comparisons

Browse all stock comparisons.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ASTS or RKLB; figures are approximate and dated (as of October 2026). Verify current data before investing.